Invesco Ltd. Point Biopharma Global Inc. Transaction History

Invesco Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.67 - $9.71 $468,207 - $681,603	70,196 Added 111.81%	132,977 $886,000
Q2 2023 Aug 11, 2023	BUY	$6.86 - $10.86 $120,269 - $190,397	17,532 Added 38.75%	62,781 $568,000
Q1 2023 May 12, 2023	BUY	$6.78 - $8.1 $85,678 - $102,359	12,637 Added 38.75%	45,249 $328,000
Q4 2022 Feb 13, 2023	SELL	$5.72 - $9.78 $857,073 - $1.47 Million	-149,838 Reduced 82.13%	32,612 $237,000
Q3 2022 Nov 14, 2022	SELL	$7.24 - $10.31 $19,113 - $27,218	-2,640 Reduced 1.43%	182,450 $1.41 Million
Q2 2022 Aug 15, 2022	BUY	$5.6 - $9.5 $1.04 Million - $1.76 Million	185,090 New	185,090 $1.26 Million

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.